<DOC>
	<DOCNO>NCT01223911</DOCNO>
	<brief_summary>This trial conduct Europe . The aim clinical trial investigate safety , tolerability pharmacokinetics ( rate drug eliminate body ) NNC 151-0000-0000 subject rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>A Multiple Dose Trial NNC 0151-0000-0000 Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<criteria>CZ : Age 18 65 year ( inclusive ) A diagnosis rheumatoid arthritis least three month entry trial Active rheumatoid arthritis ( RA ) Subjects stable dos methotrexate ( include 25 mg/week ) least 4 week trial drug administration Known suspect allergy trial product relate product Body mass index ( BMI ) less 18.0 38.0 kg/m2 ( inclusive )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>